146 related articles for article (PubMed ID: 37870768)
21. A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome.
Ryg U; Seierstad T; Nilsen LB; Hellebust TP; Djupvik LH; Gustafson H; Hydal J; Kishan AU; Hole KH; Lilleby W
Front Oncol; 2022; 12():861127. PubMed ID: 35463376
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of spine stereotactic body radiotherapy for patients with large tumors in multiple vertebrae undergoing re-irradiation: Dosimetric challenge using 3 different beam delivery techniques.
Furuya T; Phua JH; Ito K; Karasawa K
Med Dosim; 2019 Winter; 44(4):415-420. PubMed ID: 30929978
[TBL] [Abstract][Full Text] [Related]
23. Surviving Over a Decade With Glioblastoma: A Clinical Course Characterized by Multiple Recurrences, Numerous Salvage Treatments, and Novel Use of Cesium-131 Tiles.
Mehta S; Vassantachart AK; Fossum CC; Yang W; Shen ZL; Chang KE; Ye JC; Chen TC; Chang EL
Cureus; 2021 Nov; 13(11):e19573. PubMed ID: 34926045
[TBL] [Abstract][Full Text] [Related]
24. Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results.
Kutuk T; Tolakanahalli R; McAllister NC; Hall MD; Tom MC; Rubens M; Appel H; Gutierrez AN; Odia Y; Mohler A; Ahluwalia MS; Mehta MP; Kotecha R
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740612
[TBL] [Abstract][Full Text] [Related]
25. Fluorescence and immune-cell infiltration of nonneoplastic, postbrachytherapy brain tissue in 5-ALA-guided resection of recurrent anaplastic meningioma: illustrative case.
Ramapriyan R; Clark VE; Martinez-Lage M; Hsueh B; Nahed BV; Curry WT; Choi BD; Carter BS
J Neurosurg Case Lessons; 2024 Feb; 7(9):. PubMed ID: 38408351
[TBL] [Abstract][Full Text] [Related]
26. Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review.
Rao AD; Rashid AS; Chen Q; Villar RC; Kobyzeva D; Nilsson K; Dieckmann K; Nechesnyuk A; Ermoian R; Alcorn S; MacDonald SM; Ladra MM; Ford EC; Winey BA; Figueiredo MLS; Chen MJ; Terezakis SA
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):634-641. PubMed ID: 29280457
[TBL] [Abstract][Full Text] [Related]
27. Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvage.
Shen CJ; Kummerlowe MN; Redmond KJ; Martinez-Gutierrez JC; Usama SM; Holdhoff M; Grossman SA; Laterra JJ; Strowd RE; Kleinberg LR
Adv Radiat Oncol; 2018; 3(4):582-590. PubMed ID: 30370358
[TBL] [Abstract][Full Text] [Related]
28. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT.
de Chavez R; Grogan G; Hug B; Howe K; Grigg A; Waterhouse D; Lane J; Glyde A; Brown E; Bydder S; Pryor D; Hargrave C; Charles PH; Hellyer J; Ebert MA
Med Dosim; 2022 Spring; 47(1):61-69. PubMed ID: 34551879
[TBL] [Abstract][Full Text] [Related]
29. Impact of different dose prescription schedules on EQD
Kumar M; Thangaraj R; Alva RC; Koushik K; Ponni A; Achar JM
J Contemp Brachytherapy; 2019 Apr; 11(2):189-193. PubMed ID: 31139229
[TBL] [Abstract][Full Text] [Related]
30. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
[TBL] [Abstract][Full Text] [Related]
31. 5-Aminolevulinic acid-assisted resection of pediatric dysembryoplastic neuroepithelial tumor: illustrative case.
Beauchamp LH; Bercu MM; Avellino AM
J Neurosurg Case Lessons; 2021 Jul; 2(4):CASE20153. PubMed ID: 35854680
[TBL] [Abstract][Full Text] [Related]
32. 5-Aminolevulinic acid for recurrent malignant gliomas: A systematic review.
Broekx S; Weyns F; De Vleeschouwer S
Clin Neurol Neurosurg; 2020 Aug; 195():105913. PubMed ID: 32447151
[TBL] [Abstract][Full Text] [Related]
33. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.
Palmer JD; Siglin J; Yamoah K; Dan T; Champ CE; Bar-Ad V; Werner-Wasik M; Evans JJ; Kim L; Glass J; Farrell C; Andrews DW; Shi W
J Neurooncol; 2015 Sep; 124(2):215-21. PubMed ID: 26024653
[TBL] [Abstract][Full Text] [Related]
34. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
[TBL] [Abstract][Full Text] [Related]
35. SU-E-T-460: Isoeffective Dose Display (EQD2) for Composite Plan of Radiosurgery and Conventional 3D Radiotherapy.
Zheng Y; Yuan J; Woods C; Machtay M; Wessels B
Med Phys; 2012 Jun; 39(6Part17):3810-3811. PubMed ID: 28517447
[TBL] [Abstract][Full Text] [Related]
36. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.
Haider SA; Lim S; Kalkanis SN; Lee IY
J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501
[TBL] [Abstract][Full Text] [Related]
37. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
38. Survival Outcomes Among Patients With High-Grade Glioma Treated With 5-Aminolevulinic Acid-Guided Surgery: A Systematic Review and Meta-Analysis.
Gandhi S; Tayebi Meybodi A; Belykh E; Cavallo C; Zhao X; Syed MP; Borba Moreira L; Lawton MT; Nakaji P; Preul MC
Front Oncol; 2019; 9():620. PubMed ID: 31380272
[No Abstract] [Full Text] [Related]
39. CyberKnife enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures.
Oermann E; Collins BT; Erickson KT; Yu X; Lei S; Suy S; Hanscom HN; Kim J; Park HU; Eldabh A; Kalhorn C; McGrail K; Subramaniam D; Jean WC; Collins SP
J Hematol Oncol; 2010 Jun; 3():22. PubMed ID: 20534128
[TBL] [Abstract][Full Text] [Related]
40. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R
Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
